Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

CoV2-Spike-D614G Citations (3)

Originally described in: Rapid assessment of SARS-CoV-2 evolved variants using virus-like particles.
Syed AM, Taha TY, Tabata T, Chen IP, Ciling A, Khalid MM, Sreekumar B, Chen PY, Hayashi JM, Soczek KM, Ott M, Doudna JA Science. 2021 Nov 4:eabl6184. doi: 10.1126/science.abl6184. PubMed Journal

Articles Citing CoV2-Spike-D614G

Articles
Apelin as a new therapeutic target for COVID-19 treatment. Park J, Park MY, Kim Y, Jun Y, Lee U, Oh CM. QJM. 2023 Mar 27;116(3):197-204. doi: 10.1093/qjmed/hcac229. PubMed
Virus-like particle - mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection. Palermo E, Alexandridi M, Di Carlo D, Muscolini M, Hiscott J. Front Cell Infect Microbiol. 2022 Dec 14;12:1079926. doi: 10.3389/fcimb.2022.1079926. eCollection 2022. PubMed
Development of novel SARS-CoV-2 viral vectors. Liu H, Liu D. Sci Rep. 2023 Aug 11;13(1):13053. doi: 10.1038/s41598-023-40370-8. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.